Next Generation Wellness: A Technology Model for Personalizing Healthcare

  • Pei-Yun Sabrina Hsueh
  • Henry Chang
  • Sreeram Ramakrishnan
Part of the Health Informatics book series (HI)

Abstract

Personalization or individualization of care is essential to the behavioral modifications and lifestyle changes that result in patient wellness (for good health or chronic disease management). The implementation of effective personalized care is hampered by the lack of reliable means to collect and process real-time data on individual contexts (preferences, constraints) and on adherence to care protocols and mechanisms to provide timely, customized cognitive coaching that is structured, consistent and informative to users.

The advent of personal embedded biosensors is creating an accumulation of patient-generated data from numerous “touch points” (data interfaces and exchanges between patient and healthcare services before, during and after traditional clinical encounters). A major technical challenge is the establishment of a patient-centered infrastructure that can:
  • Provide the customized, timely, evidence/knowledge-driven messaging based on data from multiple touch points for continuous feedback to individual patients

  • Support this functionality within an information infrastructure of multiple service providers to provide access to unified views of patients’ data across touch points and time for multiple users (patients, providers, administrators, researchers)

We propose the implementation of a cloud-based platform to support the analytics and other services to implement this infrastructure. From an IT perspective, we explore
  • Modeling of patient contexts (preferences, behaviors) within a risk-based framework

  • Calibration of individualized, evidence-based recommendations based on patient-generated data

  • Deployment of analytics functionalities within the platform model

Keywords

Personalized healthcare Patient centered-care Data Analytics Precision Medicine Personalization Analytics Watson mobile applications Knowledge coupling with data 

Notes

Acknowledgments

Many thanks to our colleagues at the IBM T.J. Watson Center and Taiwan Collaboratory who developed the earlier prototypes of the system described here.

References

  1. 1.
    Abbar S, Bouzeghoub M, Lopez S. Context-aware recommender systems: a service-oriented approach. In: Proceedings of the 3rd VLDB international workshop on personalized access, profile management, and context awareness in databases (VLDB PersDB Workshop, IBM Almaden, San Jose). 2009.Google Scholar
  2. 2.
    ABI Research. More than 30 billion devices will wirelessly connect to the internet of everything. 2013. Available at: https://www.abiresearch.com/press/more-than-30-billion-devices-will-wirelessly-conne.
  3. 3.
    Abrahamson M, et al. Insulin-treated type 2 diabetes: balancing physiologic and individual needs. Medscape Educ. 2006. http://www.medscape.org/viewprogram/5955 [last accessed 30 July 2015].
  4. 4.
    Adams J, Mounib E, Shabo A. IT-enabled personalized healthcare. IBM Institute for Business Value Report, Somers, NY. 2010.Google Scholar
  5. 5.
    Adomavicius G, Tuzhilin A. Context-aware recommender systems. In: Proceedings of the ACM conference on Recommender systems RecSys ‘08, Lausanne. 2008.Google Scholar
  6. 6.
    AHRQ. Medical expenditure panel survey. Rockville: Agency for Healthcare Research and Quality; 2014.Google Scholar
  7. 7.
    Apple Inc. HealthKit. 2015. URL: https://developer.apple.com/healthkit/. Last accessed 22 Apr 2015.
  8. 8.
    Bardel A, Wallander MA, Svärdsudd K. Factors associated with adherence to drug therapy: a population-based study. Eur J Clin Pharmacol. 2007;63:307–14.CrossRefPubMedGoogle Scholar
  9. 9.
    Brown LL, Lustralia MLA, Rankins J. A review of web-assisted interventions for diabetes management: maximizing the potential for improving health outcomes. J Diabetes Sci Technol. 2007;1(6):164–74.CrossRefGoogle Scholar
  10. 10.
    Butler M, Kane RL, McAlpine D, Kathol, RG, Fu SS, Hagedorn H, Wilt TJ. Integration of mental health/substance abuse and primary care no. 173 AHRQ Publication No. 09-E003, Agency for Healthcare Research and Quality. 2008.Google Scholar
  11. 11.
  12. 12.
    Census Bureau. 2012 national population projections. Washington (DC): Census Bureau. Available from: http://www.census.gov/population/projections/data/national/2012/summarytables.html.
  13. 13.
    Consumer Electronics Association (CEA) report. The Connected Health and Wellness Market. Online available at: http://www.ce.org/News/News-Releases/Press-Releases/2013-Press-Releases/CEA-Releases-Report-on-Dramatic-Rise-of-Connected.aspx. Last Access 24 Apr 2015.
  14. 14.
    Chang H, Chou PB, Ramakrishnan S. An ecosystem approach for healthcare services cloud. IEEE international conference on e-business engineering. (ICEBE ‘09, Macau, China). 2009.Google Scholar
  15. 15.
    Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMedGoogle Scholar
  16. 16.
    Chobanian AV, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289(19):2560–71.CrossRefPubMedGoogle Scholar
  17. 17.
    Christensen C, Grossman J, Hwang J. The innovator’s prescription: a disruptive solution for health care. New York: McGraw-Hill; 2008.Google Scholar
  18. 18.
    CMS, Office of the Actuary, National Health Statistics Group. National health expenditures by type of sponsor: calendar years 1987–2012. Baltimore: Centers for Medicare and Medicaid Services; 2012. Available at http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/tables.pdf.Google Scholar
  19. 19.
    CMSA (Case Management Society of America). The case management adherence guidelines (CMAG-1). 2004. Retrieved 16 Oct 2004, from http://www.cmsa.org/cmag/[Context Link].
  20. 20.
    Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Sr D’agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.CrossRefPubMedGoogle Scholar
  22. 22.
    Davenport JG, Harris TH. Competing on analytics: the new science of winning. Boston: Harvard Business School Press; 2007.Google Scholar
  23. 23.
    DCCT/EDIC (The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.CrossRefGoogle Scholar
  24. 24.
    DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.CrossRefPubMedGoogle Scholar
  25. 25.
    De Vries H, Kremers S, Smeets T, Brug J, Eijmael K. The effectiveness of tailored feedback and action plans in an intervention addressing multiple health behaviors. Am J Health Promot. 2008;22(6):417–25.CrossRefPubMedGoogle Scholar
  26. 26.
    Dolin RH, Alschuler L, Boyer B, Beebe C, Behlen FM, Biron PV, Shabo A. HL7 clinical document architecture, release 2. J Am Med Inform Assoc. 2006;13(1):30–9.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    The Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–71.CrossRefGoogle Scholar
  28. 28.
    DPP (Diabetes Prevention Program). NIH Publication No. 09–5099, 2008, US Department of Health and Human Services. 2008.Google Scholar
  29. 29.
    Eddy D, et al. Individualized guidelines: the potential for increasing quality and reducing costs. Ann Intern Med. 2011;154:627–34.CrossRefPubMedGoogle Scholar
  30. 30.
    Elder P, Ayala G, Harris S. Theories and intervention approaches to health-behavior change in primary care. Am J Prev Med. 1999;17(4):275–84.CrossRefPubMedGoogle Scholar
  31. 31.
    Elixhauser A, Steiner C, Harris R, Coffey R. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.CrossRefPubMedGoogle Scholar
  32. 32.
    FDA report. Mobile medication applications: guidance for industry and food and drug administration staff. 2015a. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf.
  33. 33.
    FDA report. Medical device data systems, medical image storage devices, and medical image communications devices: guidance for industry and food and drug administration staff. 2015b. http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm401996.pdf.
  34. 34.
    Gonzalez V, Goeppinger J, Lorig K. Four psychosocial theories and their application to patient education and clinical practice. Arthritis Care Res. 1990;3:132–43.PubMedGoogle Scholar
  35. 35.
    Goodman C. Comparative effectiveness research and personalized medicine: from contradiction to synergy. In: Lewin Group Report prepared for the conference of comparative effectiveness research and personalized medicine: Policy, Science, and Business, National Pharmaceutical Council and Personalized Medicine Coalition, Falls Church, VA. 2009.Google Scholar
  36. 36.
    Grol R. Improving the quality of medical care. JAMA. 2001;286(20):2578–85.CrossRefPubMedGoogle Scholar
  37. 37.
    Grundy SM, et al. Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). In: The Third Report of the National Cholesterol Education Program (NCEP) expert panel. Circulation. 2002:17;106(25):3143–421.Google Scholar
  38. 38.
    Hirst W. Connected health and the rise of the patient-consumer. Health Aff. 2014;33(2):191–3.CrossRefGoogle Scholar
  39. 39.
    Hsueh P, Lin R, Hsiao J, Zeng L, Ramakrishnan S, Chang H. Cloud-based platform for personalization in a wellness management ecosystem: why, what, and how. IEEE international conference of collaborative computing. Chicago, IL, 201.Google Scholar
  40. 40.
    Hsueh P, Lan C, Deng V, Zhu X. From clinical requirement to personalized wellness decision support: a data-driven framework for computer-supported guideline refinement. Proceedings of the 24th European Medical Informatics Conference (MIE 2012). 2012a.Google Scholar
  41. 41.
    Hsueh P, Grandison T, Zhu X, Pai H, Chang H. Challenges and requirements on privacy in enabling evidence use service on wellness cloud, frontiers in service conference. 2012b.Google Scholar
  42. 42.
    Hsueh PS, Marschollek M, Peres Y, von Cavallar S, Martin Sanchez FJ. Gap analysis of insight-driven personalized health services through patient-controlled devices. MIE 2014 Workshop, Istanbul.Google Scholar
  43. 43.
    Ho PM, Bryson LC, Rumsfeld SJ. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028–35.CrossRefPubMedGoogle Scholar
  44. 44.
    Huang X, Liu Y, Chen K, Shin WJ, Lu CJ, Kong GW, Patnaik D, Lee SH, Cortes JF, Rogers JA. Stretchable, wireless sensors and functional substrates for epidermal characterization of sweat. Small. 2014;10(15):3083–90.CrossRefPubMedGoogle Scholar
  45. 45.
    Grandison T, Hsueh P, Zeng L, Chang H. Privacy protection issues for healthcare wellness clouds. Chapter 10. In Privacy Protection Measures and Technologies in Business Organizations (Ed. GOM Yee), IGI Global, Hershey, PA, 2011.Google Scholar
  46. 46.
    Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011;8:184–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Irigaray P, et al. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother. 2007;61(10):640–58.CrossRefPubMedGoogle Scholar
  48. 48.
    IMS Institute for health care Informatics. 2012. Press Releases. Available at: http://www.imsresearch.com/news-events/presstemplate.php?pr_id=2743.
  49. 49.
    IMS Institute for health care Informatics. Avoidable costs in U.S. health care: the $200 billion opportunity from using medicines more responsibly. 2013. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII_Responsible_Use_Medicines_2013.pdf. Accessed 10 Oct 2014.
  50. 50.
    JDRF (The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group). Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1–13.CrossRefGoogle Scholar
  51. 51.
    Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, Kripalani S. Risk prediction models for hospital readmission: a systematic review. JAMA. 2011:19;306(15):1688–98.Google Scholar
  52. 52.
    Kuper H, Marmot M. Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study. J Epidemiol Community Health. 2003;57(2):147–53.PubMedCentralCrossRefPubMedGoogle Scholar
  53. 53.
    Lloyd-Jones DM, et al. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121:1768–77.CrossRefPubMedGoogle Scholar
  54. 54.
    Lopez-Meyer P, Tiffancy S, Patil Y, Sazonov E. Monitoring of cigarette smoking using wearable sensors and support vector machines. IEEE Trans Biomed Eng. 2013;60(7):1867–72.CrossRefPubMedGoogle Scholar
  55. 55.
    Luga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44.Google Scholar
  56. 56.
    Macknight C, Rockwood K. Use of the chronic disease score to measure comorbidity in the Canadian Study of Health and Aging. Int Psychogeriatr. 2001;13(Supp 1):137–42.CrossRefPubMedGoogle Scholar
  57. 57.
    Maetzlera W, Domingosc J, Srulijesa K, Ferreirac JJ, Bloemd BR. Quantitative wearable sensors for objective assessment of PD. Mov Disord. 2013;28(12):1628–37.CrossRefGoogle Scholar
  58. 58.
    Marmot MG, Rose G, Shipley M, Hamilton PJ. Employment grade and coronary heart disease in British civil servants. J Epidemiol Community Health. 1978;32(4):244–9.PubMedCentralCrossRefPubMedGoogle Scholar
  59. 59.
    Mayo Clinics Shared Decision Making resource center. Available at http://shareddecisions.mayoclinic.org/resources/general-resources/.
  60. 60.
    Mcglynn EA, Asch SM, Kerr EA. Quality of health care delivered to adults in the United States – Reply. N Engl J Med. 2003;349:1867–8.Google Scholar
  61. 61.
    Misra V, Bhansali S, Muth J, Jackson T, Lach J. NSF Nanosystems Engineering Research Center for Advanced Self-Powered Systems of Integrated Sensors and Technologies (ASSIST). Available at: http://www.nsf.gov/awardsearch/showAward?AWD_ID=1160483&HistoricalAwards=false.
  62. 62.
    Moore JH, Asselbergs FW, Williams SM. Bioinformatics challenges for genome-wide association studies. Bioinformatics. 2010;26(4):445–55.PubMedCentralCrossRefPubMedGoogle Scholar
  63. 63.
    Mori M, et al. Genetic basis of inter-individual variability in the effects of exercise on the alleviation of lifestyle-related diseases. J Physiol. 2009;587(23):5577–84.PubMedCentralCrossRefPubMedGoogle Scholar
  64. 64.
    Mcginnis JM, Williams-Russo P, Knickman JR. The case for more active policy attention to health promotion. Health Aff. 2002;21(2):78–93.CrossRefGoogle Scholar
  65. 65.
    Müller M, Kersten S. Nutrigenomics: goals and perspectives. Nat Rev Genet. 2003;4:315–22.CrossRefPubMedGoogle Scholar
  66. 66.
    Pan XR, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.CrossRefPubMedGoogle Scholar
  67. 67.
    Patel S, Mancinelli C, Bonato P, Healey J, Moy M. Using wearable sensors to monitor physical activities of patients with COPD: a comparison of classifier performance. IEEE workshop on wearable and implantable body sensor networks. 2009, Berkeley, CA. p. 234–39.Google Scholar
  68. 68.
    Peikes D, Zutshi A, Genevro J, Smith K, Parchman M, Meyers D. Early evidence on the patient-centered medical home. Final report (prepared by Mathematica Policy Research, under Contract Nos. HHSA290200900019I/HHSA29032002T and HHSA290200900019I/HHSA29032005T). AHRQ Publication No. 12-0020-EF. Rockville: Agency for Healthcare Research and Quality; 2012.Google Scholar
  69. 69.
    Pierre Y. The healthcare imperative: lowering costs and improving outcomes: workshop series summary. Washington DC: The National Academies Press; 2010. p. 141–74.Google Scholar
  70. 70.
    PricewaterhouseCooper report. Consumer intelligence series: the wearable future. Online available at: http://www.pwc.com/us/en/industry/entertainment-media/publications/consumer-intelligence-series/. Last access 24 Apr 2015.
  71. 71.
    Pharmaceutical Group of the EU Staff. Targeting adherence: improving patient outcomes in Europe through community pharmacists’ intervention adherence. PGEU policy statement on adherence to medicines. 2008.Google Scholar
  72. 72.
    Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet. 2001;69(1):124–37.PubMedCentralCrossRefPubMedGoogle Scholar
  73. 73.
    Prochaska JO, Diclemente CC, Norcross JC. In search of how people change. Am Psychol. 1992;47(9):1102–14.CrossRefPubMedGoogle Scholar
  74. 74.
    Roche HM. Nutrigenomics—new approaches for human nutrition research. J Sci Food Agric. 2006;86(8):1156–63.CrossRefGoogle Scholar
  75. 75.
    Saaristo T, Peltonen M, Keinanen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, Oksa H, Korpi-Hyovalti E, Tuomilehto J. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health. 2007;66:101–12.CrossRefPubMedGoogle Scholar
  76. 76.
    Burke SD, Sherr D, Lipman RD. Partnering with diabetes educators to improve patient outcomes. Diabetes Metab Syndr Obes. 2014;7:45–53.PubMedCentralCrossRefPubMedGoogle Scholar
  77. 77.
    Sloan KL, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003;41(6):761–74.PubMedGoogle Scholar
  78. 78.
    Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation. 2004;109(17):2068–73.CrossRefPubMedGoogle Scholar
  79. 79.
    Schaefer C, et al. The Kaiser permanente research program on genes, environment and health: a resource for genetic epidemiology in adult health and aging. In: Proceedings of 17th annual HMO research network conference, Boston, 2011.Google Scholar
  80. 80.
    Schroeder SA. We can do better — improving the health of the American people. N Engl J Med. 2007;357(12):1221–8.CrossRefPubMedGoogle Scholar
  81. 81.
    Scott CT, Caulfield T, Borgelt E, Illes J. Personal medicine—the new banking crisis. Nat Biotechnol. 2012;30:141–7.CrossRefPubMedGoogle Scholar
  82. 82.
    Sherman BW, Chris B. Beyond incentives: the impact of health care reform on employer population health management strategies. Popul Health Manag. 2014;17(2):67–70.CrossRefPubMedGoogle Scholar
  83. 83.
    Thorisson GA, Smith AV, Krishnan L, Stein LD. The international HapMap project web site. Genome Res. 2005;15(11):1592–3.PubMedCentralCrossRefPubMedGoogle Scholar
  84. 84.
    Tuomilehto J, et al. Prevention of type II diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.CrossRefPubMedGoogle Scholar
  85. 85.
    Turner RC, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study. Br Med J. 1998;316:823.CrossRefGoogle Scholar
  86. 86.
    UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53.CrossRefGoogle Scholar
  87. 87.
    van Setten M, Pokraev S, Koolwaaij J. Context-aware recommendations in the mobile tourist application COMPASS. In: Nejdl W, De Bra P, editors. Lecture notes of computer science, vol 3137. Springer, Eindhoven, The Netherlands, 2004. p. 235–44.Google Scholar
  88. 88.
    Volk RJ, Llewellyn-Thomas H, Stacey D, Elwyn G. Ten years of the International Patient Decision Aid Standards Collaboration: evolution of the core dimensions for assessing the quality of patient decision aids. BMC Med Inform Decis Making. 2013;13 Suppl 2:S1.CrossRefGoogle Scholar
  89. 89.
    Webb TL, Joseph J, Yardley L, Michie S. Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res. 2010;12(1):e4. doi: 10.2196/jmir.1376.PubMedCentralCrossRefPubMedGoogle Scholar
  90. 90.
    Welltok caféwell concierge introduction. 2015. Available at: http://welltok.com/solutions/cafewell-concierge.html.
  91. 91.
    Zimmermann A, Specht M, Lorenz A. Personalization and context management. User Model User-Adap Inter. 2006;15(3–4):275–302.Google Scholar
  92. 92.
    Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19–39.PubMedCentralPubMedGoogle Scholar
  93. 93.
    Stampfer MJ, Hu FB, Manson JE, RimmEB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Pei-Yun Sabrina Hsueh
    • 1
  • Henry Chang
    • 1
  • Sreeram Ramakrishnan
    • 2
  1. 1.Healthcare Informatics GroupIBM T.J. Watson Research CenterYorktown HeightsUSA
  2. 2.Wellness Ecosystems and Analytics, Taiwan ColloboratoryIBM T.J. Watson ResearchHawthorneUSA

Personalised recommendations